With the international spread of COVID-19, health care professionals need to be ready to provide appropriate advice, diagnostic work-up and management for patients suspected or confirmed to have the condition.
The Department of Medicine held a Memorial Service on 3 March 2020 to honour Professor Emeritus Lionel Opie, who passed away on 20 February 2020.
Our recent biennial Physicians Conference was held at the River Club in Observatory, 20-23 February 2020. For the 1st time in the history of the conference this was a joint initiative with our colleagues from Stellenbosch University.
The discovery of a rare new strain of HIV for the first time in nearly 20 years recently made headlines around the world.
The early abandonment of HIV vaccine study HVTN 702 (also known as Uhambo) in South Africa for failing to prevent infections is a huge setback in the quest to find an HIV vaccine. However, this will not deter scientists, said the University of Cape Town’s (UCT) Professor Linda-Gail Bekker.
The pair have joined the Centre as Contributing Investigators.
Tuberculosis (TB) remains a major global health threat with ~1.5 million deaths annually. Global elimination of TB is hampered by the lack of an effective vaccine. BCG is currently the only licenced TB vaccine but its efficacy is limited especially in adults.
Clinical Research Platform Academic Sean Wasserman was awarded the Stephen Lawn TB-HIV Research Leadership Prize at the 50th Union World Conference on Lung Health in Hyderabad, India.
Professor Marc Mendelson (Head of the Division of Infectious Diseases and HIV Medicine at UCT) has written a piece for The Conversation.
Two new Fellows were inducted into the University of Cape Town’s (UCT) prestigious College of Fellows at the annual fellows dinner held at Smuts Hall this week. In addition, six College of Fellows Young Researcher Awards were made.
Two University of Cape Town research groups participated in a study that examined how well a new tuberculosis vaccine works in adults.
University of Cape Town (UCT) academics Dr Shahieda Adams and Professor Mohamed Jeebhaywere part of a team that played an integral role in providing technical medical input to the legal arguments in South Africa’s historic R5-billion settlement for the gold miners who contracted silicosis and/or pulmonary tuberculosis (TB) at work.